tradingkey.logo

Auddia Inc

AUUD

4.700USD

+0.240+5.38%
Market hours ETQuotes delayed by 15 min
2.40MMarket Cap
LossP/E TTM

Auddia Inc

4.700

+0.240+5.38%
More Details of Auddia Inc Company
Auddia Inc. is a technology company. The Company is focused on the development of a proprietary artificial intelligence (AI) platform for audio and technologies for podcasts. The Company is leveraging these technologies within its audio app, faidr. Its faidr enables the consumers to listen to any amplitude modulation (AM)/ frequency modulation (FM) radio station with commercial breaks replaced with personalized audio content, including popular and new music, news, and weather. The faidr includes podcasts and exclusive content, branded faidrRadio, which includes new artist discovery, curated music stations, and Music Casts. The Company has also developed a podcasting platform that provides a suite of tools that helps Podcasters create additional digital content for their podcast episodes as well as plan their episodes, build their brand, and monetize their content with new content distribution channels.
Company Info
Ticker SymbolAUUD
Company nameAuddia Inc
IPO dateFeb 17, 2021
CEODr. Jeffrey John Thramann, M.D.
Number of employees12
Security typeOrdinary Share
Fiscal year-endFeb 17
Address1680 38Th Street
CityBOULDER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80301
Phone13032199771
Websitehttps://auddia.com/
Ticker SymbolAUUD
IPO dateFeb 17, 2021
CEODr. Jeffrey John Thramann, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
4.66K
+0.02%
Mr. Kirin M. Smith
Mr. Kirin M. Smith
President
President
--
--
Mr. John E. Mahoney
Mr. John E. Mahoney
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Shoebridge
Mr. Peter Shoebridge
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Mr. Joshua Sroge
Mr. Joshua Sroge
Independent Director
Independent Director
--
--
Mr. Nick Balletta
Mr. Nick Balletta
Independent Director
Independent Director
--
--
Mr. Emmanuel De Boucaud
Mr. Emmanuel De Boucaud
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Jeffrey John Thramann, M.D.
Dr. Jeffrey John Thramann, M.D.
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
4.66K
+0.02%
Mr. Kirin M. Smith
Mr. Kirin M. Smith
President
President
--
--
Mr. John E. Mahoney
Mr. John E. Mahoney
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter Shoebridge
Mr. Peter Shoebridge
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Mr. Joshua Sroge
Mr. Joshua Sroge
Independent Director
Independent Director
--
--
Mr. Nick Balletta
Mr. Nick Balletta
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Goldman Sachs & Company, Inc.
6.54%
White Lion Capital LLC
0.76%
Thramann (Jeffrey John)
0.75%
UBS Financial Services, Inc.
0.59%
The Vanguard Group, Inc.
0.06%
Other
91.30%
Shareholders
Shareholders
Proportion
Goldman Sachs & Company, Inc.
6.54%
White Lion Capital LLC
0.76%
Thramann (Jeffrey John)
0.75%
UBS Financial Services, Inc.
0.59%
The Vanguard Group, Inc.
0.06%
Other
91.30%
Shareholder Types
Shareholders
Proportion
Research Firm
6.54%
Individual Investor
0.84%
Venture Capital
0.76%
Investment Advisor
0.59%
Investment Advisor/Hedge Fund
0.06%
Hedge Fund
0.05%
Other
91.15%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
36
55.46K
8.94%
+37.01K
2025Q1
40
55.45K
9.13%
+36.45K
2024Q4
38
346.78K
6.11%
+134.22K
2024Q3
36
313.09K
9.98%
+61.17K
2024Q2
37
277.64K
9.87%
+19.60K
2024Q1
42
283.24K
10.40%
+52.58K
2023Q4
42
211.67K
25.49%
-39.82K
2023Q3
39
184.31K
22.07%
-27.22K
2023Q2
42
146.62K
26.09%
-101.61K
2023Q1
37
153.34K
29.83%
-44.06K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Goldman Sachs & Company, Inc.
40.60K
6.54%
+40.60K
--
Mar 31, 2025
White Lion Capital LLC
4.71K
0.76%
+4.71K
--
Mar 11, 2024
Thramann (Jeffrey John)
4.66K
0.75%
+1.00
+0.02%
Apr 04, 2025
UBS Financial Services, Inc.
3.63K
0.59%
+3.60K
+12424.14%
Mar 31, 2025
The Vanguard Group, Inc.
364.00
0.06%
--
--
May 31, 2025
Tower Research Capital LLC
301.00
0.05%
+3.00
+1.01%
Mar 31, 2025
Mahoney (John Edward)
162.00
0.03%
--
--
Apr 04, 2025
Deitsch (Stephen M)
152.00
0.02%
+1.00
+0.66%
Apr 04, 2025
Hanlon (Timothy J)
152.00
0.02%
+77.00
+102.67%
Apr 04, 2025
Birch (Thomas Carl)
76.00
0.01%
-75.00
-49.67%
Apr 04, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 27, 2025
Merger
17<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Date
Type
Ratio
Mar 27, 2025
Merger
17<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
Feb 23, 2024
Merger
25<1
KeyAI